Evidence map›Paper›PMID 36175963›Full record

ArticleImplementation science : IS2022

Stepped implementation-to-target: a study protocol of an adaptive trial to expand access to addiction medications.

James H Ford, Hannah Cheng, Michele Gassman, Harrison Fontaine, Hélène Chokron Garneau, Ryan Keith, Edward Michael, Mark P McGovern

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Implementation science : IS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05343793 (Stagewise Implementation-To-Target- Medications for Addiction Treatment), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05343793 nacompletednot on this map

Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)

TypeinterventionalSponsorStanford UniversityRan2022 to 2026Enrolled70ConditionsAddiction, OpioidArmsEnhanced Monitoring and Feedback (EMF), NIATx/MAT Academy, NIATx-Internal Facilitation (NIATx-IF), NIATx-External Facilitation (NIATx-EF)
3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

James H FordSchool of Pharmacy, Social and Administrative Sciences Division, University of Wisconsin, Madison, USA. jhfordii@wisc.edu.ORCID 0000-0003-3045-2414
Hannah ChengDepartment of Psychiatry and Behavioral Sciences, Division of Public Health & Population Sciences, Center for Behavioral Health Services and Implementation Research, Stanford University School of Medicine, Palo Alto, USA.
Michele GassmanSchool of Pharmacy, Social and Administrative Sciences Division, University of Wisconsin, Madison, USA.
Harrison FontaineDivision of Behavioral Health & Recovery, Washington State Health Care Authority, Olympia, USA.
Hélène Chokron GarneauDepartment of Psychiatry and Behavioral Sciences, Division of Public Health & Population Sciences, Center for Behavioral Health Services and Implementation Research, Stanford University School of Medicine, Palo Alto, USA.
Ryan KeithDivision of Behavioral Health & Recovery, Washington State Health Care Authority, Olympia, USA.
Edward MichaelDivision of Behavioral Health & Recovery, Washington State Health Care Authority, Olympia, USA.
Mark P McGovernDepartment of Psychiatry and Behavioral Sciences, Division of Public Health & Population Sciences, Center for Behavioral Health Services and Implementation Research, Stanford University School of Medicine, Palo Alto, USA.

Funding

Transforming health equity rhetoric to rigor: Development and validation of a novel measure assessing health equity in implementation of health interventionsP50DA054072 · NIDA · STANFORD UNIVERSITY · PI Mark P McGovern · 2022 to 2026
$18.1M
Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)R01DA052975 · NIDA · STANFORD UNIVERSITY · PI FORD, JAMES H, MCGOVERN, MARK P · 2021 to 2025
$3.3M
NIDA NIH HHS P50 DA054072NIDA NIH HHS R01 DA052975
6 · The paper itself

Abstract

backgroundIn response to the US opioid epidemic, significant national campaigns have been launched to expand access to `opioid use disorder (MOUD). While adoption has increased in general medical care settings, specialty addiction programs have lagged in both reach and adoption. Elevating the quality of implementation strategy, research requires more precise methods in tailoring strategies rather than a one-size-fits-all-approach, documenting participant engagement and fidelity to the delivery of the strategy, and conducting an economic analysis to inform decision making and policy. Research has yet to incorporate all three of these recommendations to address the challenges of implementing and sustaining MOUD in specialty addiction programs.

methodsThis project seeks to recruit 72 specialty addiction programs in partnership with the Washington State Health Care Authority and employs a measurement-based stepped implementation-to-target approach within an adaptive trial design. Programs will be exposed to a sequence of implementation strategies of increasing intensity and cost: (1) enhanced monitoring and feedback (EMF), (2) 2-day workshop, and then, if outcome targets are not achieved, randomization to either internal facilitation or external facilitation. The study has three aims: (1) evaluate the sequential impact of implementation strategies on target outcomes, (2) examine contextual moderators and mediators of outcomes in response to the strategies, and (3) document and model costs per implementation strategy. Target outcomes are organized by the RE-AIM framework and the Addiction Care Cascade. DISCUSSION: This implementation project includes elements of a sequential multiple assignment randomized trial (SMART) design and a criterion-based design. An innovative and efficient approach, participating programs only receive the implementation strategies they need to achieve target outcomes. Findings have the potential to inform implementation research and provide key decision-makers with evidence on how to address the opioid epidemic at a systems level.

trial registrationThis trial was registered at ClinicalTrials.gov (NCT05343793) on April 25, 2022.

Indexed as

Opioid-Related DisordersAdaptive Clinical Trials as TopicAnalgesics, OpioidDelivery of Health CareHumansResearch DesignWashingtonAnalgesics, OpioidAdaptive trial designAddiction treatmentImplementation strategiesMedications for opioid use disorder

Identifiers

PMID36175963
PMCPMC9524103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.